Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and genes affect hair growth and male baldness.

Testosterone affects stress hormone levels differently in adolescent and adult male rats.

Topical antiandrogens might be a good option for male-pattern baldness with fewer side effects, but more research is needed to confirm their safety and effectiveness.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Untreated congenital adrenal hyperplasia can lead to complications like stroke and needs glucocorticoid treatment.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Finasteride affects prostate development differently in male and female Mongolian gerbils.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

Testosterone increases muscle mass regardless of DHT conversion blocking.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

No clear link between androgenetic alopecia and COVID-19 was found.

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.